Traws Pharma, Inc. Other Current Assets
Traws Pharma, Inc. (TRAW) had Other Current Assets of $93.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:OtherAssetsCurrent · last filed 2026-08-14
- 2026-06-30: Other Assets, Current $93.00K.
- 2026-03-31: Other Assets, Current $138.00K.
- 2025-12-31: Other Assets, Current $89.00K.
- 2025-09-30: Other Assets, Current $92.00K.
| Period end | Other Assets, Current | Other Assets, Current as first filed |
|---|---|---|
| 2026-06-30 | $93.00K 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $138.00K 10-Q · filed 2026-05-15 | |
| 2025-12-31 | $89.00K 10-Q · filed 2026-08-14 | |
| 2025-09-30 | $92.00K 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $124.00K 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $183.00K 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $178.00K 10-K · filed 2026-04-15 | |
| 2024-09-30 | $347.00K 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $583.00K 10-Q · filed 2024-08-15 | |
| 2024-03-31 | $263.00K 10-Q · filed 2024-05-15 | |
| 2023-12-31 | $401.00K 10-K · filed 2025-03-31 | |
| 2023-09-30 | $303.00K 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $264.00K 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $68.00K 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $40.00K 10-K · filed 2024-04-01 | |
| 2022-09-30 | $303.00K 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $306.00K 10-Q · filed 2022-08-15 | |
| 2022-03-31 | $306.00K 10-Q · filed 2022-05-13 | |
| 2021-12-31 | $35.00K 10-K · filed 2023-03-30 | |
| 2021-09-30 | $97.00K 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $191.00K 10-Q · filed 2021-08-16 | |
| 2021-03-31 | $213.00K 10-Q · filed 2021-05-17 | |
| 2020-12-31 | $180.00K 10-K · filed 2022-03-21 | |
| 2020-09-30 | $197.00K 10-Q · filed 2020-11-16 | |
| 2020-06-30 | $312.00K 10-Q · filed 2020-08-12 | |
| 2020-03-31 | $222.00K 10-Q · filed 2020-05-15 | |
| 2019-12-31 | $140.00K 10-K · filed 2021-03-18 | |
| 2019-09-30 | $89.00K 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $91.00K 10-Q · filed 2019-08-14 | |
| 2019-03-31 | $102.00K 10-Q · filed 2019-05-15 | |
| 2018-12-31 | $68.00K 10-K · filed 2020-03-27 | |
| 2018-09-30 | $103.00K 10-Q · filed 2018-11-14 | |
| 2018-06-30 | $83.00K 10-Q · filed 2018-08-14 | |
| 2018-03-31 | $225.00K 10-Q · filed 2018-05-15 | |
| 2017-12-31 | $77.00K 10-K · filed 2019-04-01 | |
| 2017-09-30 | $121.00K 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $84.00K 10-Q · filed 2017-08-14 | |
| 2017-03-31 | $104.00K 10-Q · filed 2017-05-15 | |
| 2016-12-31 | $73.00K 10-K · filed 2018-03-16 | |
| 2016-09-30 | $97.00K 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $269.00K 10-Q · filed 2016-08-15 | |
| 2016-03-31 | $206.00K 10-Q · filed 2016-05-11 | |
| 2015-12-31 | $195.00K 10-K · filed 2017-03-29 | |
| 2015-09-30 | $114.00K 10-Q · filed 2015-11-12 | |
| 2015-06-30 | $278.00K 10-Q · filed 2015-08-13 | |
| 2015-03-31 | $287.00K 10-Q · filed 2015-05-15 | |
| 2014-12-31 | $255.00K 10-K · filed 2016-03-28 | $387.00K 10-K · filed 2015-03-30 |
| 2014-09-30 | $412.00K 10-Q · filed 2014-11-14 | |
| 2014-06-30 | $337.00K 10-Q · filed 2014-08-14 | |
| 2014-03-31 | $520.00K 10-Q · filed 2014-05-15 | |
| 2013-12-31 | $449.00K 10-K · filed 2015-03-30 | |
| 2013-09-30 | $395.00K 10-Q · filed 2013-11-14 | |
| 2013-06-30 | $1.18M 10-Q · filed 2013-09-06 | |
| 2012-12-31 | $195.00K 10-K · filed 2014-03-20 | $296.00K 10-Q · filed 2013-09-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |